Total medical devices industry cross border deals worth $2.6bn were announced globally for November 2022, with WerfenLife’s $2bn acquisition deal with Immucor being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 42.7% over the previous month of $4.54bn and a drop of 11.9% when compared with the last 12-month average of $2.95bn.

In terms of number of cross border deals, the sector saw a drop of 33.33% with 42 deals in November 2022 when compared to the last 12-month average of 63 deals.

In value terms, North America led the activity with cross border deals worth $2.52bn in November 2022.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Medical Devices industry cross border deals in November 2022: Top deals

The top five cross border deals accounted for 96.3% of the overall value during November 2022.

The combined value of the top five cross border deals stood at $2.5bn, against the overall value of $2.6bn recorded for the month.

The top five medical devices industry cross border deals of November 2022 tracked by GlobalData were:

1) WerfenLife’s $2bn acquisition deal with Immucor

2) The $449m private equity of 18% stake in Certara by Arsenal Capital Partners

3) Jolt Capital’s $20.16m private equity deal with BC Platforms

4) The $18.67m private equity of StageZero Life Sciences by GEM Global YieldSCS

5) Advanced MedTech Holdings and Lyndon Rive’s $12.4m venture financing deal with Sonomotion